REQUEST A DEMO
Total
USD $0.00
Search more companies

Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) (China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Xuanzhu Biopharmaceutical Co. Ltd. Profile Updated: February 10, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) is an enterprise located in China, with the main office in Beijing. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on July 12, 2026. In its most recent financial highlights, the company reported a net sales revenue increase of 72.03% in 2025. Its’ total assets recorded a growth of 37.08%. In 2025, Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司)’s net profit margin increased by 1374.76%.

Headquarters
2107, Building 2, Zhubang 2000 Business Center, Balizhuang Xili, Chaoyang District
Beijing; Beijing;

Contact Details: Purchase the Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) report to view the information.

Website: http://www.xuanzhubio.com

Basic Information
Outstanding Shares:
Purchase the Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) report to view the information.
Incorporation Date:
July 12, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
Beijing Xuanzhu Combio Co., Ltd.
100%
Shandong Xuanzhu Pharma Co., Ltd.
100%
Xuanzhu (Beijing) Biopharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Xuanzhu Biopharmaceutical Co. Ltd. (轩竹生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
72.03%
Total Operating Revenue
59.13%
Operating Profit
58.59%
EBITDA
61.12%
Net Profit/Loss for the Period
55.88%
Total Assets
37.08%
Total Equity
43.23%
Operating Profit Margin
1425.94%
Net Profit Margin
1374.76%
Return on Equity (ROE)
40.24%
Debt / Equity
-0.11%
Quick Ratio
1.62%
Cash Ratio
2.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?